SEARCH RESULTS for: Anti-anginal [Drug Class] (11 results)

• 

• 

RANEXA (ranolazine) tablet, film coated, extended release

NDC Code(s): 43353-880-83
• Packager: Aphena Pharma Solutions - Tennessee, LLC
• This is a repackaged label.
• Source NDC Code(s): 61958-1003

• 

• 

RANEXA (ranolazine) tablet, film coated, extended release

NDC Code(s): 68151-5004-1
• Packager: Carilion Materials Management
• This is a repackaged label.
• Source NDC Code(s): 61958-1003

• 

• 

RANEXA (ranolazine) tablet, film coated, extended release

NDC Code(s): 61958-1003-1, 61958-1003-2, 61958-1003-3, 61958-1004-1, view more
61958-1004-2, 61958-1004-3
• Packager: Gilead Sciences, Inc.

• 

• 

RANEXA (ranolazine) tablet, film coated, extended release

NDC Code(s): 61958-1001-1, 61958-1002-1
• Packager: Gilead Sciences, Inc.

• 

• 

RANOLAZINE tablet, extended release

NDC Code(s): 27241-125-02, 27241-126-02
• Packager: Ajanta Pharma Limited

• 

• 

RANOLAZINE tablet, extended release

NDC Code(s): 63304-017-05, 63304-017-28, 63304-017-60, 63304-018-05, view more
63304-018-28, 63304-018-60
• Packager: Sun Pharmaceutical Industries, Inc.

• 

• 

RANOLAZINE tablet, film coated, extended release

NDC Code(s): 45963-418-06, 45963-418-50, 45963-419-06, 45963-419-50
• Packager: Actavis Pharma, Inc.

• 

• 

RANOLAZINE tablet, film coated, extended release

NDC Code(s): 69097-221-02, 69097-221-03, 69097-221-12, 69097-222-02, view more
69097-222-03, 69097-222-12
• Packager: Cipla USA Inc.

• 

• 

RANOLAZINE tablet, film coated, extended release

NDC Code(s): 51407-225-60, 51407-226-60
• Packager: Golden State Medical Supply Inc.
• This is a repackaged label.
• Source NDC Code(s): 50228-423 , 50228-424

• 

• 

RANOLAZINE tablet, film coated, extended release

NDC Code(s): 68180-354-02, 68180-354-07, 68180-355-02, 68180-355-07
• Packager: Lupin Pharmaceuticals, Inc.

• 

• 

RANOLAZINE tablet, film coated, extended release

NDC Code(s): 50228-423-05, 50228-423-30, 50228-423-60, 50228-424-05, view more
50228-424-30, 50228-424-60
• Packager: ScieGen Pharmaceuticals, Inc